SB 486: Gluten disclaimer; required disclosures for dietary supplements and medication.

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Required disclosures for dietary supplements and medication; gluten disclaimer. Requires any person who manufactures, distributes, or sells or offers for sale a dietary supplement to label such dietary supplement with a list of active and inactive ingredients and include a separate disclaimer if the product contains gluten. The bill requires pharmacists, when dispensing a prescription drug, to provide all information required under federal law to accompany the drug, including the medication guide, patient package insert, or other written patient information. The bill also requires pharmacists to provide counseling consistent with federally required labels to patients upon request when dispensing a nonprescription drug. The bill has a delayed effective date of July 1, 2027.

Sponsors

Sponsors by party (alphabetical): Republican 1

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

1. March 10, 2026Left in Health and Human Services
2. February 26, 2026Subcommittee recommends continuing to 2027 (Voice Vote)
3. February 23, 2026Assigned sub: Social Services
4. February 12, 2026Referred to Committee on Health and Human Services
5. February 12, 2026Read first time
6. February 12, 2026Placed on Calendar
7. February 9, 2026Fiscal Impact Statement from Department of Planning and Budget (SB486)
8. February 9, 2026Read third time and passed Senate (40-Y 0-N 0-A)
9. February 6, 2026Engrossed by Senate - committee substitute Block Vote (Voice Vote)
10. February 6, 2026Finance and Appropriations Substitute agreed to
11. February 6, 2026Read second time
12. February 5, 2026Passed by for the day

Showing 12 most recent of 23 actions. Full history